Morganroth J - Search Results

1

New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS Investigators.

Wyse DG, Morganroth J, Ledingham R, Denes P, Hallstrom A, Mitchell LB, Epstein AE, Woosley RL, Capone R. Wyse DG, et al. Among authors: morganroth j. J Am Coll Cardiol. 1994 Apr;23(5):1130-40. doi: 10.1016/0735-1097(94)90601-7. J Am Coll Cardiol. 1994. PMID: 8144779 Free article. Clinical Trial.

2

Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients.

Capone RJ, Pawitan Y, el-Sherif N, Geraci TS, Handshaw K, Morganroth J, Schlant RC, Waldo AL. Capone RJ, et al. Among authors: morganroth j. J Am Coll Cardiol. 1991 Nov 15;18(6):1434-8. doi: 10.1016/0735-1097(91)90671-u. J Am Coll Cardiol. 1991. PMID: 1939943 Free article. Clinical Trial.

3

Proarrhythmia, arrhythmogenesis or aggravation of arrhythmia--a status report, 1987.

Horowitz LN, Zipes DP, Bigger JT Jr, Campbell RW, Morganroth J, Podrid PJ, Rosen MR, Woosley RL. Horowitz LN, et al. Among authors: morganroth j. Am J Cardiol. 1987 Apr 30;59(11):54E-56E. doi: 10.1016/0002-9149(87)90204-9. Am J Cardiol. 1987. PMID: 3578042 Free article. No abstract available.

4

Prediction of cardiac death in patients with a very low ejection fraction after myocardial infarction: a Cardiac Arrhythmia Suppression Trial (CAST) study.

Josephson RA, Chahine RA, Morganroth J, Anderson J, Waldo A, Hallstrom A. Josephson RA, et al. Among authors: morganroth j. Am Heart J. 1995 Oct;130(4):685-91. doi: 10.1016/0002-8703(95)90064-0. Am Heart J. 1995. PMID: 7572573 Clinical Trial.

5

Pharmacokinetics of moricizine HCl.

Woosley RL, Morganroth J, Fogoros RN, McMahon FG, Humphries JO, Mason DT, Williams RL. Woosley RL, et al. Among authors: morganroth j. Am J Cardiol. 1987 Oct 16;60(11):35F-39F. doi: 10.1016/0002-9149(87)90718-1. Am J Cardiol. 1987. PMID: 3310583 Review.

6

Treatment of ventricular arrhythmias by United States cardiologists: a survey before the Cardiac Arrhythmia Suppression Trial results were available.

Morganroth J, Bigger JT Jr, Anderson JL. Morganroth J, et al. Am J Cardiol. 1990 Jan 1;65(1):40-8. doi: 10.1016/0002-9149(90)90023-t. Am J Cardiol. 1990. PMID: 1688481 Clinical Trial.

7

Antiarrhythmic drug therapy 1988: for whom, how and where?

Morganroth J, Horowitz LN. Morganroth J, et al. Am J Cardiol. 1988 Sep 1;62(7):461-5. doi: 10.1016/0002-9149(88)90979-4. Am J Cardiol. 1988. PMID: 3414523 No abstract available.

8

Application of a frequency definition of ventricular proarrhythmia.

Morganroth J, Borland M, Chao G. Morganroth J, et al. Am J Cardiol. 1987 Jan 1;59(1):97-9. doi: 10.1016/s0002-9149(87)80078-4. Am J Cardiol. 1987. PMID: 3812259

9

Pharmacologic management of ventricular arrhythmias after the cardiac arrhythmia suppression trial.

Morganroth J, Bigger JT Jr. Morganroth J, et al. Am J Cardiol. 1990 Jun 15;65(22):1497-503. doi: 10.1016/0002-9149(90)91362-a. Am J Cardiol. 1990. PMID: 2091621 Clinical Trial. No abstract available.

10

Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine).

Morganroth J, Pratt CM. Morganroth J, et al. Am J Cardiol. 1989 Jan 15;63(3):172-6. doi: 10.1016/0002-9149(89)90280-4. Am J Cardiol. 1989. PMID: 2642632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters